G

genOway Tech Stack

Genetically engineered preclinical models and cell lines for drug development

Biotechnology Research Lyon, Auvergne-Rhone-Alpes 51–200 employees Founded 1999 Public Company

genOway supplies genetically modified mice, rats, and cell lines to pharma and biotech researchers—a 25-year-old business now pivoting toward AI and internal modernization. Active projects span transgenic line creation via reimplantation and IVF, cryoconservation workflows, and an explicit AI integration roadmap, while hiring velocity is accelerating across research (largest department), engineering, and ops. Pain-point data reveals simultaneous pressure on carbon reduction (6% annually through 2026), procurement optimization, and non-technical AI adoption—typical of a research-operations org scaling both its science and its infrastructure.

Tech Stack 20 technologies

Core StackReact Node.js Java Python Docker Kubernetes AWS Terraform GraphQL Adobe Photoshop Adobe Illustrator Adobe InDesign HubSpot Hugging Face LangChain CSS Azure Webflow FileMaker Excel

What genOway Is Building

◆Challenges

Reducing carbon footprint
Optimize procurement volumes
Recrutement de talents
Adoption of ai tools by non-technical teams
Improving recruitment processes
Modernizing recruitment tools
International recruitment challenges
Reduce carbon footprint by 30%

▲Active Projects

Building evolution projects
Action plan deployment
Procurement strategy roadmap
Transgenic line creation via reimplantation
Transgenic line amplification via ivf
Cryoconservation of transgenic lines
Ai integration roadmap
Cross-functional genai projects
Carbon footprint reduction initiative
Amplification and monitoring of mouse models

Hiring Activity

Accelerating20 roles · 9 in 30d

Department

Research

7

HR

3

Engineering

2

Ops

2

Sales

2

Data

1

Manufacturing

1

Marketing

1

Seniority

Junior

5

Manager

5

Mid

5

Intern

2

Lead

1

Senior

1

Company intelligence

Find more companies like genOway by tech stack, pain points and active projects

Get started free

About genOway

genOway develops customized and catalog-ready genetically engineered mouse, rat, and cell line models for preclinical research. The company serves 17 of the world's largest pharma companies alongside biotech firms, CROs, and academic institutions. Founded in 1999 and headquartered in Lyon, genOway employs 150+ researchers and specialists from 17 nationalities. The product portfolio ranges from CRISPR/Cas9–generated knockouts and humanized models to ready-to-use validated cell lines, all designed to increase predictability in translating preclinical findings to clinical success. The company maintains sourcing partnerships with certified breeders in the US and Europe and commits to greenhouse-gas reduction targets launched in 2021.

HeadquartersLyon, Auvergne-Rhone-Alpes

Company Size51–200 employees

Founded1999

Hiring MarketsFrance

Frequently Asked Questions

What is genOway's tech stack?

genOway uses React, Node.js, Java, and Python for development; Docker and Kubernetes for containerization; AWS and Azure for cloud infrastructure; Terraform for IaC; GraphQL for APIs; HubSpot for CRM; and Hugging Face and LangChain for AI tooling.

What is genOway working on?

Active projects include transgenic line creation and amplification (via reimplantation and IVF), cryoconservation workflows, AI integration roadmap, cross-functional GenAI projects, procurement strategy optimization, and carbon footprint reduction initiatives.